Hdl cholesterol levels and cardiovascular risk
Pro Research Analysisby 
Searched over 200M research papers
HDL Cholesterol Levels and Cardiovascular Risk: Key Insights
Inverse Relationship Between HDL Cholesterol and Cardiovascular Disease Risk
Many large studies have shown that higher levels of high-density lipoprotein cholesterol (HDL-C) are generally linked to a lower risk of cardiovascular disease (CVD) and cardiovascular mortality. This inverse relationship is consistent across genders, age groups, and different risk categories, with higher HDL-C levels offering protective effects against both CVD and coronary heart disease (CHD) mortality 7910. Even in patients treated with statins and those with very low low-density lipoprotein cholesterol (LDL-C), higher HDL-C levels are associated with a reduced risk of major cardiovascular events .
U-Shaped and Nonlinear Associations: Risks at Very High HDL-C Levels
Recent research has challenged the idea that higher HDL-C is always better. Several studies have found a U-shaped or nonlinear relationship, where both low and very high HDL-C levels are associated with increased cardiovascular risk. In patients with coronary artery disease (CAD) and in hypertensive individuals, very high HDL-C levels (above 80 mg/dL) are linked to higher all-cause and cardiovascular mortality, especially in men 134. This pattern has been observed in diverse populations, including European and Asian cohorts, and is independent of genetic factors that influence HDL-C 134.
Changes in HDL-C Levels and Cardiovascular Risk
For people who already have high HDL-C levels (≥60 mg/dL), further increases in HDL-C may actually raise the risk of CVD and coronary heart disease, regardless of changes in LDL-C . This suggests that simply increasing HDL-C in those with already high levels does not provide additional cardiovascular protection and may even be harmful .
Genetic and Pharmacological Insights
Genetic studies and trials targeting HDL-C have shown that raising HDL-C through certain mechanisms, such as inhibiting cholesterol ester transfer protein (CETP), does not always reduce cardiovascular events and may sometimes increase risk . Mendelian randomization analyses indicate that the protective effect of HDL-C is most evident at low levels (≤50 mg/dL), with little to no additional benefit at higher concentrations .
HDL-C as a Marker Versus a Target
While low HDL-C is a strong independent risk factor for CVD, especially in men, it often occurs alongside other metabolic issues like high triglycerides and insulin resistance . Therefore, HDL-C is a useful marker for cardiovascular risk, but interventions should focus on overall metabolic health rather than just raising HDL-C .
Conclusion
HDL cholesterol plays a complex role in cardiovascular risk. While low HDL-C is clearly associated with higher risk, very high HDL-C levels may also increase the risk of adverse cardiovascular outcomes. The relationship between HDL-C and cardiovascular risk is not simply linear; both very low and very high levels can be harmful. Effective cardiovascular risk management should focus on maintaining HDL-C within a healthy range and addressing other metabolic risk factors, rather than aiming for excessively high HDL-C levels.
Sources and full results
Most relevant research papers on this topic